Concepts (154)
Concepts are derived automatically from a person's publications.
Concepts are listed by decreasing relevance which is based on many factors, including how many publications the person wrote about that topic, how long ago those publications were written, and how many publications other people have written on that same topic.
| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Retinopathy of Prematurity | 4 | 2018 | 88 | 1.220 |
Why?
|
| Autonomic Nervous System | 2 | 2018 | 72 | 1.110 |
Why?
|
| Dacryocystorhinostomy | 2 | 2018 | 44 | 0.880 |
Why?
|
| Nasolacrimal Duct | 2 | 2018 | 53 | 0.870 |
Why?
|
| Strabismus | 6 | 2009 | 213 | 0.710 |
Why?
|
| Lacrimal Duct Obstruction | 1 | 2018 | 53 | 0.650 |
Why?
|
| Oculomotor Muscles | 4 | 2009 | 179 | 0.570 |
Why?
|
| Accommodation, Ocular | 1 | 2015 | 33 | 0.520 |
Why?
|
| Esotropia | 1 | 2015 | 54 | 0.510 |
Why?
|
| Heart Rate | 1 | 2018 | 737 | 0.510 |
Why?
|
| Sympathomimetics | 1 | 2014 | 16 | 0.510 |
Why?
|
| Caffeine | 1 | 2014 | 87 | 0.480 |
Why?
|
| Psychomotor Performance | 1 | 2015 | 233 | 0.460 |
Why?
|
| Dexamethasone | 1 | 2018 | 1450 | 0.460 |
Why?
|
| Anisometropia | 4 | 2005 | 24 | 0.440 |
Why?
|
| Patient Compliance | 3 | 2015 | 667 | 0.440 |
Why?
|
| Dopamine | 1 | 2014 | 312 | 0.430 |
Why?
|
| Central Nervous System Stimulants | 1 | 2014 | 225 | 0.430 |
Why?
|
| Preoperative Care | 1 | 2018 | 1529 | 0.420 |
Why?
|
| Amblyopia | 4 | 2005 | 112 | 0.390 |
Why?
|
| Ophthalmologic Surgical Procedures | 2 | 2009 | 177 | 0.340 |
Why?
|
| Visual Acuity | 8 | 2015 | 873 | 0.310 |
Why?
|
| Photography | 2 | 2009 | 139 | 0.300 |
Why?
|
| Sclerostomy | 1 | 2007 | 5 | 0.300 |
Why?
|
| Suture Techniques | 2 | 2007 | 319 | 0.300 |
Why?
|
| Eye Movements | 2 | 2006 | 116 | 0.300 |
Why?
|
| Exotropia | 1 | 2006 | 23 | 0.290 |
Why?
|
| Diagnostic Techniques, Ophthalmological | 2 | 2004 | 104 | 0.290 |
Why?
|
| Sclera | 1 | 2007 | 69 | 0.280 |
Why?
|
| Tendons | 1 | 2006 | 84 | 0.280 |
Why?
|
| Needles | 1 | 2007 | 107 | 0.280 |
Why?
|
| Ophthalmoplegia | 2 | 2003 | 79 | 0.280 |
Why?
|
| Infant, Low Birth Weight | 2 | 2018 | 181 | 0.270 |
Why?
|
| Infant | 9 | 2021 | 13310 | 0.250 |
Why?
|
| Photorefractive Keratectomy | 4 | 2005 | 77 | 0.230 |
Why?
|
| Silicone Elastomers | 1 | 2003 | 49 | 0.230 |
Why?
|
| Intubation | 1 | 2003 | 40 | 0.230 |
Why?
|
| Eye Abnormalities | 1 | 2004 | 118 | 0.220 |
Why?
|
| Cornea | 2 | 2005 | 638 | 0.220 |
Why?
|
| Treatment Refusal | 1 | 2004 | 128 | 0.220 |
Why?
|
| Child, Preschool | 13 | 2018 | 16273 | 0.220 |
Why?
|
| Optic Nerve | 1 | 2004 | 133 | 0.220 |
Why?
|
| Foreign-Body Migration | 1 | 2003 | 117 | 0.210 |
Why?
|
| Hyperopia | 4 | 2015 | 84 | 0.210 |
Why?
|
| Retinal Diseases | 1 | 2004 | 179 | 0.200 |
Why?
|
| Treatment Failure | 1 | 2004 | 1391 | 0.200 |
Why?
|
| Depth Perception | 2 | 2015 | 34 | 0.190 |
Why?
|
| Lacrimal Apparatus | 1 | 2021 | 181 | 0.170 |
Why?
|
| Injections, Intravenous | 1 | 2018 | 573 | 0.150 |
Why?
|
| Glucocorticoids | 3 | 2018 | 629 | 0.150 |
Why?
|
| Eyeglasses | 2 | 2015 | 32 | 0.150 |
Why?
|
| Infant, Newborn | 5 | 2018 | 8223 | 0.140 |
Why?
|
| Aging | 1 | 2004 | 1582 | 0.140 |
Why?
|
| Child | 14 | 2021 | 29154 | 0.140 |
Why?
|
| Follow-Up Studies | 4 | 2018 | 14889 | 0.130 |
Why?
|
| Laser Coagulation | 2 | 2007 | 136 | 0.130 |
Why?
|
| Intensive Care Units, Neonatal | 2 | 2014 | 273 | 0.130 |
Why?
|
| Infant, Very Low Birth Weight | 2 | 2014 | 165 | 0.130 |
Why?
|
| Retrospective Studies | 9 | 2018 | 37905 | 0.130 |
Why?
|
| Gestational Age | 3 | 2014 | 1069 | 0.130 |
Why?
|
| Vision Tests | 2 | 2004 | 66 | 0.120 |
Why?
|
| Retinal Detachment | 2 | 2005 | 88 | 0.120 |
Why?
|
| Risk Factors | 4 | 2018 | 17523 | 0.110 |
Why?
|
| Asphyxia Neonatorum | 1 | 2012 | 15 | 0.110 |
Why?
|
| Humans | 26 | 2021 | 261506 | 0.100 |
Why?
|
| Mydriatics | 3 | 2009 | 26 | 0.100 |
Why?
|
| Female | 18 | 2021 | 141928 | 0.100 |
Why?
|
| Male | 16 | 2018 | 123000 | 0.090 |
Why?
|
| Hypothermia, Induced | 1 | 2012 | 170 | 0.090 |
Why?
|
| Myopia | 4 | 2005 | 194 | 0.090 |
Why?
|
| Case-Control Studies | 2 | 2018 | 6100 | 0.090 |
Why?
|
| Torsion Abnormality | 1 | 2009 | 38 | 0.090 |
Why?
|
| Postoperative Complications | 2 | 2018 | 5542 | 0.080 |
Why?
|
| Lasers, Semiconductor | 1 | 2007 | 14 | 0.080 |
Why?
|
| Microscopy, Acoustic | 1 | 2007 | 26 | 0.070 |
Why?
|
| Retina | 2 | 2007 | 532 | 0.070 |
Why?
|
| Oxidative Stress | 1 | 2012 | 1129 | 0.070 |
Why?
|
| Treatment Outcome | 5 | 2018 | 32848 | 0.070 |
Why?
|
| Anatomy, Cross-Sectional | 1 | 2004 | 24 | 0.060 |
Why?
|
| Sensory Deprivation | 1 | 2004 | 35 | 0.060 |
Why?
|
| Atropine | 1 | 2004 | 52 | 0.060 |
Why?
|
| Body Weights and Measures | 1 | 2004 | 52 | 0.060 |
Why?
|
| Retinoscopy | 1 | 2004 | 10 | 0.060 |
Why?
|
| Nose | 1 | 2006 | 192 | 0.060 |
Why?
|
| Efficiency, Organizational | 1 | 2004 | 88 | 0.060 |
Why?
|
| Lasers, Excimer | 4 | 2005 | 86 | 0.060 |
Why?
|
| Chorioretinitis | 1 | 2003 | 4 | 0.060 |
Why?
|
| Toxoplasmosis, Ocular | 1 | 2003 | 3 | 0.060 |
Why?
|
| Toxoplasmosis, Congenital | 1 | 2003 | 3 | 0.060 |
Why?
|
| Panuveitis | 1 | 2003 | 4 | 0.060 |
Why?
|
| Refractive Errors | 1 | 2004 | 95 | 0.060 |
Why?
|
| Diagnosis, Computer-Assisted | 1 | 2004 | 164 | 0.060 |
Why?
|
| Astigmatism | 1 | 2004 | 156 | 0.050 |
Why?
|
| Vision Disorders | 1 | 2004 | 245 | 0.050 |
Why?
|
| Trochlear Nerve Diseases | 1 | 2002 | 6 | 0.050 |
Why?
|
| Intracranial Hypotension | 1 | 2002 | 11 | 0.050 |
Why?
|
| Oculomotor Nerve Diseases | 1 | 2002 | 27 | 0.050 |
Why?
|
| Anesthesia, General | 1 | 2003 | 239 | 0.050 |
Why?
|
| Prospective Studies | 6 | 2007 | 12873 | 0.050 |
Why?
|
| Blepharoptosis | 1 | 2002 | 70 | 0.050 |
Why?
|
| Epithelium, Corneal | 1 | 2003 | 223 | 0.050 |
Why?
|
| Myasthenia Gravis | 1 | 2002 | 99 | 0.050 |
Why?
|
| Endoscopy | 1 | 2003 | 479 | 0.040 |
Why?
|
| Edema | 1 | 2021 | 267 | 0.040 |
Why?
|
| Tropicamide | 2 | 2009 | 8 | 0.040 |
Why?
|
| Wound Healing | 1 | 2003 | 815 | 0.040 |
Why?
|
| Phenylephrine | 2 | 2009 | 48 | 0.040 |
Why?
|
| Pain, Postoperative | 1 | 2003 | 610 | 0.040 |
Why?
|
| Parents | 1 | 2004 | 998 | 0.040 |
Why?
|
| Pupil | 2 | 2009 | 54 | 0.040 |
Why?
|
| Stents | 1 | 2003 | 1096 | 0.040 |
Why?
|
| Time Factors | 2 | 2006 | 12926 | 0.030 |
Why?
|
| Age Factors | 1 | 2004 | 5377 | 0.030 |
Why?
|
| Corneal Topography | 2 | 2005 | 168 | 0.030 |
Why?
|
| Drug Therapy, Combination | 3 | 2004 | 2315 | 0.030 |
Why?
|
| Apgar Score | 1 | 2012 | 55 | 0.030 |
Why?
|
| Hydrogen Peroxide | 1 | 2012 | 217 | 0.020 |
Why?
|
| Inflammation | 1 | 2021 | 2522 | 0.020 |
Why?
|
| Birth Weight | 1 | 2012 | 374 | 0.020 |
Why?
|
| Iris | 1 | 2009 | 67 | 0.020 |
Why?
|
| Reproducibility of Results | 3 | 2004 | 6009 | 0.020 |
Why?
|
| Pilot Projects | 2 | 2005 | 2803 | 0.020 |
Why?
|
| Adolescent | 2 | 2004 | 31252 | 0.020 |
Why?
|
| Adult | 4 | 2009 | 77950 | 0.020 |
Why?
|
| Vitreous Hemorrhage | 1 | 2005 | 11 | 0.020 |
Why?
|
| Vitreous Body | 1 | 2005 | 123 | 0.020 |
Why?
|
| Office Management | 1 | 2004 | 9 | 0.020 |
Why?
|
| Practice Management | 1 | 2004 | 12 | 0.020 |
Why?
|
| Cyclopentolate | 1 | 2004 | 8 | 0.020 |
Why?
|
| Community Participation | 1 | 2004 | 53 | 0.020 |
Why?
|
| Sulfadiazine | 1 | 2003 | 2 | 0.010 |
Why?
|
| Pyrimethamine | 1 | 2003 | 4 | 0.010 |
Why?
|
| Toxoplasma | 1 | 2003 | 14 | 0.010 |
Why?
|
| DNA, Protozoan | 1 | 2003 | 35 | 0.010 |
Why?
|
| Antiprotozoal Agents | 1 | 2003 | 40 | 0.010 |
Why?
|
| Antibodies, Protozoan | 1 | 2003 | 87 | 0.010 |
Why?
|
| Leucovorin | 1 | 2003 | 332 | 0.010 |
Why?
|
| Safety | 1 | 2004 | 465 | 0.010 |
Why?
|
| Pyridostigmine Bromide | 1 | 2002 | 15 | 0.010 |
Why?
|
| Refraction, Ocular | 1 | 2004 | 289 | 0.010 |
Why?
|
| Diplopia | 1 | 2002 | 66 | 0.010 |
Why?
|
| Thymectomy | 1 | 2002 | 79 | 0.010 |
Why?
|
| Middle Aged | 2 | 2009 | 86204 | 0.010 |
Why?
|
| Cholinesterase Inhibitors | 1 | 2002 | 110 | 0.010 |
Why?
|
| Immunoglobulin G | 1 | 2003 | 1021 | 0.010 |
Why?
|
| Pain Measurement | 1 | 2003 | 953 | 0.010 |
Why?
|
| Caregivers | 1 | 2004 | 677 | 0.010 |
Why?
|
| Sensitivity and Specificity | 1 | 2004 | 4971 | 0.010 |
Why?
|
| Epithelial Cells | 1 | 2003 | 1818 | 0.010 |
Why?
|
| Disease Progression | 1 | 2003 | 6682 | 0.010 |
Why?
|
| Combined Modality Therapy | 1 | 2002 | 8865 | 0.010 |
Why?
|
| Magnetic Resonance Imaging | 1 | 2002 | 7702 | 0.000 |
Why?
|
| Aged | 1 | 2009 | 70117 | 0.000 |
Why?
|
| Animals | 1 | 2003 | 59536 | 0.000 |
Why?
|